肝细胞癌的免疫检查点抑制剂治疗期间肝功能的演变
Katharina Pomej1,2, Lorenz Balcar1,2, Sabrina Sidali3
1Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
United European gastroenterology journal
|July 11, 2024
概括
免疫检查点抑制剂 (ICI) 可以改善或稳定晚期肝细胞癌 (HCC) 患者的肝功能. 这种肝功能改善与更好的生存结果有关,即使对于那些在基线时患有Child-Pugh类B的人来说.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝功能恶化是晚期肝细胞癌 (HCC) 死亡的主要原因.
- 免疫检查点抑制剂 (ICI) 越来越多地用于HCC治疗,但它们对肝功能的影响需要评估.
研究的目的:
- 评估ICI治疗对晚期HCC患者肝功能的影响.
- 确定肝功能变化与患者的治疗结果 (包括生存时间) 之间的相关性.
主要方法:
- 对接受ICI或索拉芬尼布治疗的HCC患者的回顾性分析.
- 在基线,治疗开始后3个月和6个月使用Child-Pugh评分 (CPS) 评估肝功能.
- 在CPS的变化被分类为改善,稳定或恶化.
主要成果:
- 在182名ICI治疗患者中,56%的患者在3个月后表现出改善或稳定的肝功能,45%的患者在6个月后表现出改善或稳定的肝功能.
- 对ICI的放射性反应与肝功能改善/稳定相关 (73%对50%).
- 6个月后肝功能改善/稳定与总体存活率显著改善 (28.4 vs 14.2个月) 相关.
- 在基线Child-Pugh类B的患者中,46%的肝功能在3个月后得到改善或稳定,有些人过渡到Child-Pugh类A.
结论:
- 在晚期HCC中,ICI治疗可以使肝功能稳定或改善.
- 放射性反应和改善的肝功能与增强的生存率有关.
- 这些好处甚至在最初被归类为Child-Pugh类B的患者中也被观察到.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
相关概念视频
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
